154 N. Lampon & J. C. Tutor 23. Louro MO, Tutor JC. Determinación de la actividadoxidásica de la ceruloplasmina en los analizadoresCobas Bio y Cobas- Fara. Acta Bioquim Clin Latinoam. 1991;25:119–25. 24. Wai CT, Greenson JK, Fontana RJ, Kalbﬂeisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both signiﬁcant ﬁbrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38: 518–26. 25. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict signiﬁcant ﬁbrosis in patients with HIV/HCVcoin- fection. Hepatology. 2006;43:1317–25. 26. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufﬁcient sensitivity and speciﬁcity in the diagnosis of immune thrombocytopenia. Br J Hematol. 2005;128:698–702. 27. Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocyto- penia. Clin Lab Hematol. 2005;27:370–3. 28. Osselaer JC, Lamart J, Scheiff JM. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem. 1997; 43:1072–6. 29. Milne DB. Copper intake and assessment of copper status. Am J Clin Nutr. 1998;Suppl67:1041S–45S. 30. Milne DB. Trace elements. In: Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical Chemistry, Fifth edition. Philadelphia: WB Saunders Company; 2001. p. 568–83. 31. Chiang CH, Huang CC, Chan WL, Chen JW, Leu HB. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently asso- ciated with increased cardiovascular risk in healthy popula- tion. Clin Biochem. 2010;43:1399–404. 32. Turecki L, Kupkova V, Mojto V, Smutny M, Uhlikova E, Vozar I. Serum activity of cholinesterase activity and proteo- synthetic function of liver in patients with diabetes mellitus. Bratisl Lek Listy. 2005;106:266–9. 33. Sridar GR, Rao AA, Srinivas K, Nirmala G, Lakshmi G, Suryanarayna D, et al. Butyrylcholinesterase in metabolic syndrome. Med Hypotheses. 2010;75:648–51. 34. Kawasaki S, Hasegawa O, Satoh S, Numata K, Terauchi Y. Sonographic assessment of fatty liver using the measurement of para-and perirenal fat thickness. J Clin Ultrasound. 2010; 38:470–4. 35. Das UN. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inﬂammation. Med Sci Monit. 2007;13:RA124–1. 36. Rao AA, Sridhar GR, Das UN. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes and Alzheimer’s disease. Med Hypotheses. 2007;69:1272–6. 37. Puche E, Garcia-Morillas M, Garcia de la Serrana H, Mota C. Probable pseudocholinesterase induction by valproic acid, carbamazepine and phenytoin leading to increasedserum aspirin-esterase activity in epileptics. Int J Clin Pharm Res. 1989;9:309–11. 38. Tutor-Crespo MJ, Hermida J, Tutor JC. Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels. J Clin Pharmacol. 2004;44:974–80. 39. Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, et al. Effects of antiepileptic drugs on lipids, homocysteine, and c-reactive protein. Ann Neurol. 2009;65:448–56. 40. Tao TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang WN, et al. Long-term antiepileptic drug therapy con- tributes to the acceleration of atherosclerosis. Epilepsia. 2009; 50:1579–86. 41. Gerstner T, Teich M, Bell N, Longin E, Dempﬂe CE, Brand J, et al. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2006;47: 1136–43. 42. Mannaerts I, Nuytten NR, Rogiers V, Vanderkerken K, van Grunsven LA, Geerts A. Chronic administration of val- proic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo. Hepatology. 2010;51:603–14. 43. Nakagawa T, Muramoto Y, Hori M, Mihara S, Marubayashi T, Nakagawa K. A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease. Cin Chim Acta. 2008;398:34–8.